Investigation by Pomerantz Law Firm for Investors of NeoGenomics, Inc.
On August 6, 2025, Pomerantz LLP announced their investigation into potential claims on behalf of investors of NeoGenomics, Inc. (NASDAQ: NEO). This investigation is rooted in serious concerns that the company, alongside its officers and directors, may have engaged in illegal securities practices. Following NeoGenomics' recent financial disclosure, the firm is seeking to protect the rights of investors who are possibly facing losses due to these alleged unlawful activities.
On July 29, 2025, NeoGenomics released its second-quarter financial results, which unfortunately did not meet market expectations. The company reported revenue of $181.3 million, which fell significantly short of analysts’ predictions, alongside a net loss of $45.1 million. In light of these alarming results, NeoGenomics altered its revenue forecast for 2025, now estimating earnings between $720 million and $726 million— a decrease from the previous forecast of approximately $753 million. Furthermore, the company also adjusted its EBITDA projections, now expecting a range of $41 million to $44 million, a reduction from prior forecasts of $55 million to $58 million.
This chain of negative announcements led to a drastic fall in NeoGenomics' stock price, dropping $1.21 per share—equivalent to an 18.73% decline, closing at $5.25 per share on the day the financial results were announced. Pomerantz LLP recognizes the importance of acting swiftly in these matters, as the impending potential class action could provide necessary recourse for affected shareholders. If you are an investor and have suffered losses from your investments in NeoGenomics, it's critical that you reach out to Pomerantz LLP promptly.
The law firm, with branches in key locations including New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, boasts a strong reputation as a leader in corporate, securities, and antitrust class action litigation. Founded by Abraham L. Pomerantz, known as a pioneer in the field of securities class actions, Pomerantz has continued to advocate for victims of corporate breaches and misconduct for over 85 years. The firm has successfully secured numerous multi-million dollar settlements for its clients, reaffirming its commitment to seeking justice for investors.
For any investors interested in learning more about this situation, Pomerantz LLP encourages impacted parties to connect with Danielle Peyton directly at [email protected] or by calling 646-581-9980, extension 7980. As this investigation unfolds, staying informed will be crucial for all concerned shareholders. Pomerantz LLP continues to uphold its mission of fighting against securities fraud and defending the legal rights of investors who may have been wronged.
On July 29, 2025, NeoGenomics released its second-quarter financial results, which unfortunately did not meet market expectations. The company reported revenue of $181.3 million, which fell significantly short of analysts’ predictions, alongside a net loss of $45.1 million. In light of these alarming results, NeoGenomics altered its revenue forecast for 2025, now estimating earnings between $720 million and $726 million— a decrease from the previous forecast of approximately $753 million. Furthermore, the company also adjusted its EBITDA projections, now expecting a range of $41 million to $44 million, a reduction from prior forecasts of $55 million to $58 million.
This chain of negative announcements led to a drastic fall in NeoGenomics' stock price, dropping $1.21 per share—equivalent to an 18.73% decline, closing at $5.25 per share on the day the financial results were announced. Pomerantz LLP recognizes the importance of acting swiftly in these matters, as the impending potential class action could provide necessary recourse for affected shareholders. If you are an investor and have suffered losses from your investments in NeoGenomics, it's critical that you reach out to Pomerantz LLP promptly.
The law firm, with branches in key locations including New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, boasts a strong reputation as a leader in corporate, securities, and antitrust class action litigation. Founded by Abraham L. Pomerantz, known as a pioneer in the field of securities class actions, Pomerantz has continued to advocate for victims of corporate breaches and misconduct for over 85 years. The firm has successfully secured numerous multi-million dollar settlements for its clients, reaffirming its commitment to seeking justice for investors.
For any investors interested in learning more about this situation, Pomerantz LLP encourages impacted parties to connect with Danielle Peyton directly at [email protected] or by calling 646-581-9980, extension 7980. As this investigation unfolds, staying informed will be crucial for all concerned shareholders. Pomerantz LLP continues to uphold its mission of fighting against securities fraud and defending the legal rights of investors who may have been wronged.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.